PHARMA WAR: Pfizer and Moderna Are Now Fighting Each Other, Here’s How

Since the end of the pandemic, both Pfizer and Moderna shares have dropped due to an exponential amount of people refusing to be boosted by the pharmaceutical companies’ new boosters.

Now it appears the ongoing financial pressure is causing the two vaccine giants to turn on each other.

A new report has revealed Pfizer has asked a U.S. court to revoke Moderna’s Covid-19 vaccine patents.

In the new court filing, Pfizer told the US Patent and Trademark’s offices board that Moderna has “coopted the entire field of messenger RNA technology.”

Moderna has yet to respond to the filing.

Pfizer Asks Court To Revoke Moderna's COVID-19 Vaccine Patents https://t.co/ZbULXaO6GH

— zerohedge (@zerohedge) September 4, 2023

Here’s what Zero Hedge reported:

Pfizer and its partner BioNTech have asked a U.S. court to revoke Moderna’s patents for COVID-19 vaccine technology.

Pfizer and BioNTech said in new filings to the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board that Moderna’s patents are so broad that they essentially “coopt the entire field” of messenger RNA technology, which is used in some COVID-19 vaccines.

The patents, obtained during the COVID-19 pandemic, are “unimaginably broad” and cover technology that was known long before 2015, when Moderna says it developed the technology, one filing stated.

Moderna didn’t respond to a request for comment.

One Moderna patent being challenged covers messenger RNA vaccines with the spike protein or spike protein subunit of any betacoronavirus, such as COVID-19, delivered into the human body through a lipid delivery system. Another covers similar technology.

Pfizer and BioNTech are seeking an inter partes review of a trial at the board that would go over whether the technology Moderna patented was already described.

Scientists found in 1990 that messenger RNA could be used in ways that would improve vaccines, and in 1993, scientists found that vaccines with the technology produced an immune response, Pfizer and BioNTech told the court.

Pfizer Calls for Court Interference to Nullify Moderna's COVID Vaccine Patents #PfizerModernaPatentDispute #COVID19VaccineBattle #JudicialInterventionVaccine https://t.co/DPUZUiaj0U

— Mercado Magazine (@mercadonewsmag) September 4, 2023

Per The Epoch Times:

Pfizer and its partner BioNTech have asked a U.S. court to revoke Moderna’s patents for COVID-19 vaccine technology.

Pfizer and BioNTech said in new filings to the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board that Moderna’s patents are so broad that they essentially “coopt the entire field” of messenger RNA technology, which is used in some COVID-19 vaccines.

The patents, obtained during the COVID-19 pandemic, are “unimaginably broad” and cover technology that was known long before 2015, when Moderna says it developed the technology, one filing stated.

One Moderna patent being challenged covers messenger RNA vaccines with the spike protein or spike protein subunit of any betacoronavirus, such as COVID-19, delivered into the human body through a lipid delivery system. Another covers similar technology.

Pfizer and its partner BioNTech have asked a U.S. court to revoke Moderna's patents for COVID-19 vaccine technology.https://t.co/SuGGWqdgTf

— Badlands Media (@BadlandsMedia_) September 4, 2023